Five brands, examined ingredient by ingredient. A considered guide to copper creams, rich balms and the evidence behind the promise.
CoreAge Rx appears first as a commercial partner. The other selections illustrate different formulations and buying models; position is not a clinical score.
Bounce Back brings copper-peptide skincare into an online prescribing service.
Product page says 2%; help catalog says 0.2%. Confirm the dispensed strength.
Post-procedure marketing does not replace the treating clinician’s wound-care plan.
Blue Copper 5 combines copper positioning with a separate matrikine peptide complex.
Ingredient studies and consumer perceptions are different from finished-product comparative trials.
Super Cop is a richly colored cream with a complex ingredient list.
The formula includes additional active and aromatic ingredients; review the complete label.
A 1% product name is not directly comparable with a different peptide mixture.
A copper-peptide cream offered through clinical review, with a public concentration discrepancy that needs resolving.
A rich recovery cream whose occlusive base is a major part of the product’s identity.
A cosmetic cream with several kinds of supporting evidence that should be read separately.
The regular copper-peptide cream, examined through its full ingredient list rather than its strength language.
A squalane-rich gel or balm alternative with a modified copper peptide and manufacturer-reported testing.
Ask what was tested, on whom, against what and for how long before comparing a headline result.
Peptide identity, concentration terminology and the base all matter to a comparison.
A richer texture is a formulation choice, not a clinical effectiveness score.
Recovery marketing should not replace instructions from the professional responsible for the procedure.
Separate container prices, subscription commitments and professional care before judging value.
Evaluate one proposed addition against the products and instructions already in place.
We read product pages, published research, and regulatory guidance. We explain the tradeoffs, distinguish marketing from evidence, and link the sources so you can look closer.
Read our methodology